BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 36571343)

  • 1. Converging links between adult-onset neurodegenerative Alzheimer's disease and early life neurodegenerative neuronal ceroid lipofuscinosis?
    Klein M; Hermey G
    Neural Regen Res; 2023 Jul; 18(7):1463-1471. PubMed ID: 36571343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Converging roles of PSENEN/PEN2 and CLN3 in the autophagy-lysosome system.
    Klein M; Kaleem A; Oetjen S; Wünkhaus D; Binkle L; Schilling S; Gjorgjieva M; Scholz R; Gruber-Schoffnegger D; Storch S; Kins S; Drewes G; Hoffmeister-Ullerich S; Kuhl D; Hermey G
    Autophagy; 2022 Sep; 18(9):2068-2085. PubMed ID: 34964690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endosomal Trafficking in Alzheimer's Disease, Parkinson's Disease, and Neuronal Ceroid Lipofuscinosis.
    Qureshi YH; Baez P; Reitz C
    Mol Cell Biol; 2020 Sep; 40(19):. PubMed ID: 32690545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy in the Neuronal Ceroid Lipofuscinoses (Batten Disease).
    Kim WD; Wilson-Smillie MLDM; Thanabalasingam A; Lefrancois S; Cotman SL; Huber RJ
    Front Cell Dev Biol; 2022; 10():812728. PubMed ID: 35252181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses.
    Mukherjee AB; Appu AP; Sadhukhan T; Casey S; Mondal A; Zhang Z; Bagh MB
    Mol Neurodegener; 2019 Jan; 14(1):4. PubMed ID: 30651094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cln3-mutations underlying juvenile neuronal ceroid lipofuscinosis cause significantly reduced levels of Palmitoyl-protein thioesterases-1 (Ppt1)-protein and Ppt1-enzyme activity in the lysosome.
    Appu AP; Bagh MB; Sadhukhan T; Mondal A; Casey S; Mukherjee AB
    J Inherit Metab Dis; 2019 Sep; 42(5):944-954. PubMed ID: 31025705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel c.1135_1138delCTGT mutation in CLN3 leads to juvenile neuronal ceroid lipofuscinosis.
    Drack AV; Miller JN; Pearce DA
    J Child Neurol; 2013 Sep; 28(9):1112-6. PubMed ID: 23877479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal triaging of misfolded proteins by adult neuronal ceroid lipofuscinosis-associated DNAJC5/CSPα mutants causes lipofuscin accumulation.
    Lee J; Xu Y; Saidi L; Xu M; Zinsmaier K; Ye Y
    Autophagy; 2023 Jan; 19(1):204-223. PubMed ID: 35506243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease).
    Hawkins-Salsbury JA; Cooper JD; Sands MS
    Biochim Biophys Acta; 2013 Nov; 1832(11):1906-9. PubMed ID: 23747979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional brain atrophy in mouse models of neuronal ceroid lipofuscinosis: a new rostrocaudal perspective.
    Kühl TG; Dihanich S; Wong AM; Cooper JD
    J Child Neurol; 2013 Sep; 28(9):1117-22. PubMed ID: 24014506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuronal ceroid lipofuscinoses: Opportunities from model systems.
    Faller KM; Gutierrez-Quintana R; Mohammed A; Rahim AA; Tuxworth RI; Wager K; Bond M
    Biochim Biophys Acta; 2015 Oct; 1852(10 Pt B):2267-78. PubMed ID: 25937302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuronal ceroid-lipofuscinoses.
    Goebel HH
    J Child Neurol; 1995 Nov; 10(6):424-37. PubMed ID: 8576551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease).
    Ouseph MM; Kleinman ME; Wang QJ
    Ann N Y Acad Sci; 2016 May; 1371(1):55-67. PubMed ID: 26748992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuronal ceroid-lipofuscinoses: a historical introduction.
    Haltia M; Goebel HH
    Biochim Biophys Acta; 2013 Nov; 1832(11):1795-800. PubMed ID: 22959893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of CLN3, the gene mutated in juvenile neuronal ceroid lipofuscinosis, leads to metabolic impairment and autophagy induction in retinal pigment epithelium.
    Zhong Y; Mohan K; Liu J; Al-Attar A; Lin P; Flight RM; Sun Q; Warmoes MO; Deshpande RR; Liu H; Jung KS; Mitov MI; Lin N; Butterfield DA; Lu S; Liu J; Moseley HNB; Fan TWM; Kleinman ME; Wang QJ
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165883. PubMed ID: 32592935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of the neuronal ceroid lipofuscinoses (Batten disease).
    Mole SE; Cotman SL
    Biochim Biophys Acta; 2015 Oct; 1852(10 Pt B):2237-41. PubMed ID: 26026925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect.
    de los Reyes E; Dyken PR; Phillips P; Brodsky M; Bates S; Glasier C; Mrak RE
    J Child Neurol; 2004 Jan; 19(1):42-6. PubMed ID: 15032383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of model organisms for the study of neuronal ceroid lipofuscinosis.
    Bond M; Holthaus SM; Tammen I; Tear G; Russell C
    Biochim Biophys Acta; 2013 Nov; 1832(11):1842-65. PubMed ID: 23338040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Insights in Elucidation of Possible Molecular Mechanisms of the Juvenile Form of Batten Disease.
    Shematorova EK; Shpakovski GV
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33137890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the Neuroimaging Phenotype of Neuronal Ceroid Lipofuscinoses.
    Biswas A; Krishnan P; Amirabadi A; Blaser S; Mercimek-Andrews S; Shroff M
    AJNR Am J Neuroradiol; 2020 Oct; 41(10):1930-1936. PubMed ID: 32855186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.